Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Key Studies in Hematologic Malignancies: Independent Conference Coverage of the 2021 ASCO Scientific Meeting
  • CME

Ian W. Flinn, MD, PhD
Shaji K. Kumar, MD
Eunice S. Wang, MD
Released: September 13, 2021
Back Next

Introduction

In this module, Ian W. Flinn, MD, PhD; Shaji Kumar, MD; and Eunice S. Wang, MD, offer an overview of key studies on hematologic malignancies presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting. The studies focus on hematologic malignancies, including novel therapies and long-term updates of key clinical trials.

First, Shaji Kumar, MD, will discuss key studies on the care of patients with multiple myeloma (MM). Eunice S. Wang, MD, will then explore top studies related to the care of patients with leukemias. Lastly, Ian W. Flinn, MD, PhD, will review the most clinically relevant studies in chronic lymphocytic leukemia (CLL) and other lymphomas.

The key points discussed in this module are illustrated with thumbnails from the accompanying downloadable PowerPoint slidesets, which can be found here or downloaded by clicking any of the slide thumbnails in the module alongside the expert commentary.

Clinical Care Options plans to measure the educational impact of this activity. Several questions will be asked twice: once at the beginning of the activity and then once again after the discussion that informs the best choice. Your responses will be aggregated for analysis, and your specific responses will not be shared.

Before continuing with this educational activity, please take a moment to answer the following questions.

Back Next
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
AstraZeneca
Bristol-Myers Squibb
GlaxoSmithKline
Novartis Pharmaceuticals Corporation
Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.
Sanofi Genzyme

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue